Tsu Hsu

461 total citations
21 papers, 361 citations indexed

About

Tsu Hsu is a scholar working on Oncology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Tsu Hsu has authored 21 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Molecular Biology. Recurrent topics in Tsu Hsu's work include Peptidase Inhibition and Analysis (11 papers), Neuropeptides and Animal Physiology (11 papers) and Diabetes Treatment and Management (7 papers). Tsu Hsu is often cited by papers focused on Peptidase Inhibition and Analysis (11 papers), Neuropeptides and Animal Physiology (11 papers) and Diabetes Treatment and Management (7 papers). Tsu Hsu collaborates with scholars based in Taiwan. Tsu Hsu's co-authors include Weir‐Torn Jiaang, Chia‐Hui Chien, Shiow‐Ju Lee, Xin Chen, Yu‐Sheng Chao, Yuan‐Shou Chen, Teng‐Kuang Yeh, Chih‐Hsiang Huang, Chiung‐Tong Chen and Jen‐Shin Song and has published in prestigious journals such as Journal of Medicinal Chemistry, Life Sciences and European Journal of Medicinal Chemistry.

In The Last Decade

Tsu Hsu

21 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tsu Hsu Taiwan	11	161	148	112	98	82	21	361
Kai‐Chia Yeh Taiwan	11	163 1.0×	113 0.8×	53 0.5×	33 0.3×	40 0.5×	18	315
Ana Krivokuća Serbia	15	179 1.1×	188 1.3×	92 0.8×	32 0.3×	24 0.3×	46	559
Thomas Fuchß Germany	13	175 1.1×	417 2.8×	114 1.0×	20 0.2×	38 0.5×	29	614
Catherine Magill United States	7	137 0.9×	153 1.0×	76 0.7×	90 0.9×	24 0.3×	10	397
Jean‐Bernard Falmagne Belgium	9	183 1.1×	257 1.7×	297 2.7×	105 1.1×	97 1.2×	11	621
Cornelia E. Hoesl Germany	10	84 0.5×	166 1.1×	173 1.5×	39 0.4×	18 0.2×	18	377
Chie Hatori Japan	14	96 0.6×	279 1.9×	300 2.7×	73 0.7×	22 0.3×	19	747
Christelle David France	10	97 0.6×	208 1.4×	93 0.8×	104 1.1×	91 1.1×	13	521
Koc-Kan Ho United States	12	73 0.5×	328 2.2×	64 0.6×	26 0.3×	16 0.2×	17	476
NICHOLAS B. LYDON Switzerland	6	62 0.4×	274 1.9×	55 0.5×	33 0.3×	102 1.2×	9	434

Countries citing papers authored by Tsu Hsu

Since Specialization

Citations

This map shows the geographic impact of Tsu Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsu Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsu Hsu more than expected).

Fields of papers citing papers by Tsu Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsu Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsu Hsu. The network helps show where Tsu Hsu may publish in the future.

Co-authorship network of co-authors of Tsu Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Tsu Hsu. A scholar is included among the top collaborators of Tsu Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsu Hsu. Tsu Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Hsin-Huei, Tsu Hsu, Yi‐Hui Peng, et al.. (2024). Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization. Journal of Medicinal Chemistry. 67(23). 21106–21125. 4 indexed citations

Yeh, Kai‐Chia, Teng‐Kuang Yeh, Min‐Hsien Wang, et al.. (2021). DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity. Life Sciences. 278. 119574–119574. 10 indexed citations

Peng, Yi‐Hui, Tsu Hsu, Chih‐Hsiang Huang, et al.. (2021). Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2). Journal of Medicinal Chemistry. 64(15). 11288–11301. 15 indexed citations

Yeh, Teng‐Kuang, Yu‐Chi Chou, Tsu Hsu, et al.. (2020). Potent and orally active purine-based fetal hemoglobin inducers for treating β-thalassemia and sickle cell disease. European Journal of Medicinal Chemistry. 209. 112938–112938. 5 indexed citations

Lin, Wen‐Hsing, Yi‐Hui Peng, Tsu Hsu, et al.. (2016). Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK). Journal of Medicinal Chemistry. 59(8). 3906–3919. 26 indexed citations

Chen, Chiung-Tong, John T.-A. Hsu, Wen‐Hsing Lin, et al.. (2015). Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations. European Journal of Medicinal Chemistry. 100. 151–161. 8 indexed citations

Lin, Wen‐Hsing, John Hsu, Chiung‐Tong Chen, et al.. (2013). Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3). Bioorganic & Medicinal Chemistry. 21(11). 2856–2867. 14 indexed citations

Hsu, John T.-A., Teng‐Kuang Yeh, Shih-Chieh Yen, et al.. (2012). 3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3). Bioorganic & Medicinal Chemistry Letters. 22(14). 4654–4659. 6 indexed citations

Lin, Wen‐Hsing, Shih-Chieh Yen, Chiung‐Tong Chen, et al.. (2011). Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3). Bioorganic & Medicinal Chemistry. 19(14). 4173–4182. 14 indexed citations

10.

Hsu, Tsu, et al.. (2011). Synthesis of 3,3‐Dimethylglutamic Acid Derivatives as DPP‐IV Inhibitors and Evaluation of Their Chemical Stability. Journal of the Chinese Chemical Society. 58(1). 108–117. 2 indexed citations

11.

Yeh, Teng‐Kuang, Tsu Hsu, Jai‐Hong Cheng, et al.. (2010). (2S,4S)-1-[2-(1,1-Dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry Letters. 20(12). 3596–3600. 15 indexed citations

12.

Lin, Chi-Hung, et al.. (2010). Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents. Investigational New Drugs. 30(1). 164–175. 10 indexed citations

13.

Hsu, Tsu, Chiung‐Tong Chen, Jai‐Hong Cheng, et al.. (2009). (1,3‐Diphenyl‐1H‐Pyrazol‐4‐yl)‐Methylamine Analogues as Inhibitors of Dipeptidyl Peptidases. Journal of the Chinese Chemical Society. 56(5). 1048–1055. 7 indexed citations

14.

Hsu, Tsu, Chiung‐Tong Chen, Jai‐Hong Cheng, et al.. (2009). Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(7). 1908–1912. 22 indexed citations

15.

Hsu, Tsu, Chiung‐Tong Chen, Jai‐Hong Cheng, et al.. (2009). Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry. 17(6). 2388–2399. 15 indexed citations

16.

Coumar, Mohane Selvaraj, Chiung‐Tong Chen, Xin Chen, et al.. (2006). 3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes. Bioorganic & Medicinal Chemistry Letters. 17(5). 1274–1279. 10 indexed citations

17.

Coumar, Mohane Selvaraj, Tsu Hsu, Hsing‐Pang Hsieh, et al.. (2006). Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(12). 3268–3272. 16 indexed citations

18.

Tseng, Huan‐Yi, Wen‐Hsin Huang, Yung‐Ning Yang, et al.. (2005). Benzothiazolium compounds: novel classes of inhibitors that suppress the nitric oxide production in RAW264.7 cells stimulated by LPS/IFNγ. Bioorganic & Medicinal Chemistry Letters. 15(8). 2027–2032. 18 indexed citations

19.

Jiaang, Weir‐Torn, et al.. (2005). Novel Isoindoline Compounds for Potent and Selective Inhibition of Prolyl Dipeptidase DPP8.. ChemInform. 36(25). 2 indexed citations

20.

Jiaang, Weir‐Torn, Yuan‐Shou Chen, Tsu Hsu, et al.. (2004). Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8. Bioorganic & Medicinal Chemistry Letters. 15(3). 687–691. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact